Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
10/2003
10/23/2003WO2003087098A1 Nitrogen-containing bicyclic heterocycles for use as antibacterials
10/23/2003WO2003087095A1 Quinolinone derivatives
10/23/2003WO2003086404A1 Fused quinoxaline derivatives as inhibitors of akt activity
10/23/2003WO2003086394A1 Inhibitors of akt activity
10/23/2003WO2003002064A3 Fused pyrimidine dhfr inhibitors as antibacterials
10/23/2003CA2480860A1 Tri-substituted heteroaryls and methods of making and using the same
10/23/2003CA2448525A1 Nitrogen-containing bicyclic heterocycles for use as antibacterials
10/22/2003CN1125071C Phthalocyanine and use of phthalocyanine as marking agent
10/22/2003CN1125070C Pyrrolo [2,3-d] pyrmidine compounds, and compositions and use thereof
10/22/2003CN1125069C Preparation of alkylthio-and/or arylthio-substd. diketo-diaryl-pyrrolopyrroles
10/21/2003US6635762 Monocyclic-7H-pyrrolo[2,3-d]pyrimidine compounds, compositions, and methods of use
10/21/2003US6635650 Such as N-(2-(7-(2-((8-(2-(acetyl-amino)ethyl)-2-naphthyl) oxy)ethoxy)-1-napthyl)ethyl)acetamide for treating or preventing melatoninergic disorders
10/21/2003US6635633 Substituted pyrazoles useful for treating autoimmune diseases mediated by cathepsin S
10/16/2003WO2003084975A1 New analogs of nitrobenzylthioinosine
10/16/2003WO2003084955A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity
10/16/2003WO2003084954A1 Tropane derivatives as ccr5 modulators
10/16/2003WO2003050064A3 Mitotic kinesin inhibitors
10/16/2003US20030195221 Substituted indolizine-like compounds and methods of use
10/16/2003US20030195196 Pyrrolobenzodiazepines
10/16/2003CA2462708A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity
10/15/2003EP1352910A1 New analogs of nitrobenzylthioinosine
10/15/2003EP1351916A2 Ether compounds and compositions for cholesterol management and related uses
10/15/2003EP0888351B1 Pyrimido 5,4-d]pyrimidines, medicaments containing these compounds, their use and process for their production
10/09/2003WO2003082832A2 Anxiolytic agents with reduced sedative and ataxic effects
10/09/2003WO2003082350A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
10/09/2003CA2480869A1 Anxiolytic agents with reduced sedative and ataxic effects
10/08/2003CN1447803A Hyperpolarizable organic chromophores
10/08/2003CN1123573C 2-phenyl substituted imidazotrizainones as phosphodiesterase inhibitors
10/07/2003US6630472 Compounds, pharmaceutical compositions, and methods for stimulating neuronal growth and elongation
10/07/2003CA2287552C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
10/02/2003WO2003080624A2 Dithiolopyrrolone derivatives useful in the treatment of proliferative diseases
10/02/2003WO2002000656A3 Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives
10/02/2003US20030187251 Porphyrin array having imidazolyl porphyrin metal complex as structural unit thereof and method of producing the same
10/02/2003US20030186982 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
10/01/2003EP1348708A1 Heteroaryl substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)one derivatives
10/01/2003EP1347982A2 Spiro isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines
10/01/2003EP1347974A1 Aminotriazolopyridiine derivatives as adenosine receptor ligands
09/2003
09/30/2003US6627639 Useful in the treatment of central nervous system disorders including depression, obsessive compulsive disorder, panic attacks, generalized anxiety disorder, sexual dysfunction, eating disorders and addictive disorders caused by ethanol or
09/30/2003US6626566 Compounds for electronic devices
09/25/2003WO2003078440A1 Broad-spectrum cephem compounds
09/25/2003WO2003078438A1 Carbamates as hiv protease inhibitors
09/25/2003WO2003077862A2 Potent, simplified derivatives of immunosuppressive agents
09/25/2003WO2002030884A3 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
09/25/2003US20030181470 Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitors
09/25/2003US20030181455 Bicyclic and tricyclic hetroaromatic compounds
09/25/2003US20030181438 Bicyclic lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
09/25/2003US20030180575 Sulfur-containing compound and light-emitting device using same
09/25/2003CA2479354A1 Broad-spectrum cephem compounds
09/25/2003CA2478731A1 Carbamates as hiv protease inhibitors
09/24/2003EP1345606A2 Texaphyrin coordination compounds and uses thereof
09/24/2003EP1345603A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/23/2003US6624317 Taxoid conjugates as antimitotic and antitumor agents
09/23/2003US6624172 Imidazonaphthyridines
09/18/2003WO2003076446A1 Antiparasitic artemisinin derivatives (endoperoxides)
09/18/2003WO2003076443A1 Spiro compounds with npy antagonistic activity
09/18/2003WO2003076442A1 Purine derivatives as kinase inhibitors
09/18/2003WO2003076439A2 1-allyl ergot alkaloid derivatives, method for producing the same and the use thereof for preventing and treating migraine
09/18/2003WO2003076427A1 Quinazoline compounds useful in therapy
09/18/2003WO2003062445A3 Real-time linear detection probes: sensitive 5'-minor groove binder-containing probes for pcr analysis
09/18/2003US20030176670 Multivalent macrolide antibiotics
09/18/2003US20030176436 For therapy and prophylaxis of bacterial infections, or their use as antiseptics, sterilizants, or disinfectants
09/18/2003US20030175728 Real-time linear detection probes: sensitive 5'-minor groove binder-containing probes for PCR analysis
09/18/2003CA2482191A1 Spiro compounds with npy antagonistic activity
09/18/2003CA2479016A1 Quinazoline compounds useful in therapy
09/18/2003CA2478600A1 Antiparasitic artemisinin derivatives (endoperoxides)
09/17/2003EP1343789A1 Tricyclic derivatives of indole with antiangiogenic activity
09/17/2003EP1049697B1 Triazolo-pyridazine derivatives as ligands for gaba receptors
09/17/2003EP0588858B1 IMIDAZO 2,1-b] 3]BENZAZEPINE DERIVATIVES, COMPOSITIONS AND METHOD OF USE
09/16/2003US6620529 Dyes for filters, color conversion filters, photographic material dyes, sensitizing dyes, dyes for dying pulp, laser dyes, fluorescent drugs for medical diagnoses and materials for light emitting devices, and light emitting devices using
09/16/2003CA2238736C Novel a1 adenosine receptor agonists and antagonists
09/12/2003WO2003075091A1 Colour photographic recording material
09/12/2003WO2003074532A1 Heterocyclic amide derivatives as inhibitors of glycogen phosphorylase
09/12/2003WO2003074523A2 Gadolinium chelate oligomers, their use as contrast products in magnetic resonance imaging and their synthesis intermediates
09/12/2003WO2003045942A3 Chemokine receptor antagonists and methods of use thereof
09/12/2003WO2002058695A9 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/12/2003WO2002040486A3 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS
09/12/2003CA2477667A1 Heterocyclic amide derivatives as inhibitors of glycogen phosphorylase
09/11/2003US20030171584 6-Substituted pyrido-pyrimidines
09/11/2003US20030171395 Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
09/11/2003US20030171381 Therapy for Parkinson's disease; antidepressants; antiepileptic agents
09/11/2003US20030170831 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
09/11/2003US20030170141 For treating photoreactive compounds
09/11/2003US20030168970 Luminescent element material and luminescent element comprising the same
09/10/2003EP1341763A2 N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization
09/10/2003EP0912570B1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
09/09/2003US6617348 Treating or preventing osteoporosis
09/09/2003US6617334 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene
09/09/2003US6617327 For therapy of depression and other diseases such as obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders
09/04/2003WO2003073076A1 Reagent for determining the absolute configuration of chiral compound and determination method
09/04/2003WO2003072579A1 HETEROARYL SUBSTITUTED 2-PYRIDINYL AND 2-PYRIMIDINYL -6,7,8,9- TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES
09/04/2003WO2003072578A1 Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
09/04/2003WO2003048120A3 2-aryl pyrrologpyrimidines for a1 and a3 receptors
09/04/2003US20030166922 Antibiotics; therapy for antibiotic resistant infections
09/04/2003US20030166674 1-Azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors
09/04/2003CA2475773A1 Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
09/03/2003EP1341403A1 Luminescent element material and luminescent element comprising the same
09/03/2003EP1340758A1 Heteroaryl substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)one derivatives
09/03/2003EP1339716A1 Novel lactame-substituted pyrazolopyridine derivatives
09/03/2003EP1339712A1 3-substituted quinuclidines and their use as nicotinic agonists
09/03/2003EP1339699A1 Substituted amidoalkyl uracils and the use thereof
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 111